Novo Nordisk submits new Wegovy dose to the European Medicines Agency for approval
Refinitiv閱讀少於1分鐘
Denmark's Novo Nordisk 
NOVO_B said on Tuesday it had submitted a new Wegovy dose to the European Medicines Agency for approval, with one in three trial participants achieving 25% or more weight loss.
登入或建立一個永久免費帳戶來閱讀此新聞